Featured
Fintech Decree, Last Day in the Italian Senate to Submit Amendments
Among the issues raised by those present was the fact that the fintech decree does not provide for the tokenization of ltd shares or the possibility for sgr to be managers of a DLT registry. Then there is the issue of DLT technology, the exact definition of which would seem too limiting, with a view to further development of the same technology.
The new fintech decree on asset tokenization and the simplification of the regulatory sandbox, will soon be available, but some adjustments would still need to be made.
That’s what emerged last Monday, April 3rd, at the Milan office of the law firm Dentons and via a link from the same firm’s Rome office, during a meeting of some 30 insiders called together by Assofintech president Maurizio Bernardo who is also Dentons’ senior advisor supporting the firm’s multidisciplinary team dedicated to Tech, which includes the fintech and insurtech industries and an additional set of non-financial sectors, such as proptech, healthtech, foodtech, agritech, fashiontech, and greentech.
Read more details about the fintech decree and find other important financial news with our companion app Born2Invest.
Explaining the contents of the fintech decree and gathering proposals were the Honorable Giulio Centemero (League), and Vittorio Tortorici
The meeting had been called precisely to gather ideas to be submitted by today in the Senate, the last day to submit amendments to the text of conversion into law of Decree-Law No. 25 of March 17th on Urgent provisions on the issuance and circulation of certain financial instruments in digital form and the simplification of FinTech experimentation, published Friday, March 17th, in the Official Gazette.
Explaining the contents of the fintech decree and gathering proposals were the Honorable Giulio Centemero (League), a member of the House Finance Committee, and Vittorio Tortorici, senior advisor of the Treasury Department of the Ministry of Economy and Finance and Bank of Italy expert on issues dis retail payment services, collective asset management, and financial innovation.
Among the issues raised by those present was the fact that the decree does not provide for the tokenization of ltd shares or the possibility for sgr to be managers of a DLT registry. Then there is the issue of DLT technology, the exact definition of which would seem too limiting, with a view to further development of the same technology. As for the sandbox, market demands all point in the direction of introducing a temporary authorization suspension regime for experimentation with any kind of financial activity conducted by a fintech.
__
(Featured image by sergeitokmakov via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Be Beez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Rovi Cuts Its Profit by 4% in the First Nine Months, to 113.5 Million
-
Biotech4 days ago
Better Care Advances Healthcare Technology with Partnership with Oracle
-
Fintech1 week ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech2 days ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant